Skip to main content
. Author manuscript; available in PMC: 2023 Jan 9.
Published in final edited form as: J Surg Res. 2022 May 12;277:372–383. doi: 10.1016/j.jss.2022.04.052

Table 1 –

Clinical characteristics of patients in two main clusters.

Clinical characteristics Cluster I early disrupted homeostasis (N = 18) Cluster II early preserved homeostasis (N = 139) P value

Demographics
Age, median (25th, 75th) 64 (56, 69) 62 (50, 70) 0.35
Male gender, n (%) 11 (61) 74 (53) 0.62
Race, n (%)
 White 15 (83) 124 (89) 0.07
 African American 1 (6) 12 (9)
 American Indian 0 (0) 1 (0.7)
Transferred from another hospital, n (%) 8 (44) 64 (46) 1.00
Weight (kg), median (25th, 75th) 98 (64, 136) 86 (71, 103) 0.28
Body Mass index, median (25th, 75th) 35 (21, 45) 29 (25, 34) 0.36
Comorbidities, n (%)
Chronic kidney disease* 7 (47) 15 (11) 0.001
Congestive heart failure 7 (39) 20 (14) 0.02
Chronic obstructive pulmonary disease 2 (12) 17 (12) 1.00
Diabetes mellitus 8 (47) 45 (33) 0.28
Hypertension 13 (76) 81 (59) 0.20
Smoking history, n (%)
 Current 4 (24) 57 (42) 0.21
 Former 1 (6) 15 (11)
 Never 12 (71) 64 (47)
Characteristics of sepsis episode
Sepsis severity, n (%)
 Sepsis 0 (0) 57 (41) < 0.001
 Severe sepsis 4 (22) 58 (42)
 Septic shock 14 (78) 24 (17)
Acuity scores in the first 24 h of sepsis onset, median (25th, 75th)
APACHE II 30 (26, 39) 16 (11, 21) < 0.001
 Total acute physiology score 23 (20, 34) 12 (8, 17) < 0.001
 Age points 4 (3, 5) 3 (2, 5) 0.19
 Chronic health points 0 (0, 2) 0 (0, 0) 0.001
SOFA 13 (11, 15) 5 (2, 8) < 0.001
 Respiratory system 3 (2, 3) 0 (0, 3) < 0.001
 Central nervous system 3 (2, 4) 1 (0, 2) 0.002
 Cardiovascular system 3 (3, 4) 1 (0, 1) < 0.001
 Liver 1 (0, 2) 0 (0, 0) < 0.001
 Coagulation 0.5 (0, 2) 0 (0, 0) 0.002
 Renal 3 (2, 4) 0 (0, 1) < 0.001

Abbreviations: APACHE II = Acute Physiology and Chronic Health Evaluation II score; SOFA = Sequential Organ Failure Assessment.

Pairs that are significant with P values at 0.05 level are boldfaced.

*

Percentages calculated after removing end-stage renal disease (ESRD) patients from the cohort.

Due to missing values, the percentages were calculated based on the available data.